
Reset all filters
01 11AbbVie Inc
02 2Allergan Aesthetics
03 3Omgene Life Sciences Pvt. Ltd
04 1Actavis Inc
05 1AstraZeneca
06 2Aurobindo Pharma Limited
07 2Laboratorio Eczane Pharma
08 1ORIFARM GROUP AS
09 2Viatris
Reset all filters
01 3CAPSULE
02 8CAPSULE;ORAL
03 5Capsule
04 2Capsule, hard
05 1Hard Capsule
06 3Hard Gelatin Capsule
07 3Kapsel, hard
Reset all filters
01 2Allowed
02 1Approved
03 1Authorized
04 4DISCN
05 3Prescription
06 3RX
07 11Blank
Reset all filters
01 1Axulta
02 3CONSTELLA
03 8Constella
04 5LINACLOTIDE
05 3LINZESS
06 2Lilla
07 3Linaclotide
Reset all filters
01 2Argentina
02 3Canada
03 3India
04 5Norway
05 1Spain
06 1Sweden
07 2Switzerland
08 8USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LINZESS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 145MCG
Packaging :
Approval Date : 2012-08-30
Application Number : 202811
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Constella
Dosage Form : Capsule, hard
Dosage Strength : 290 mcg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Linaclotide
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 72MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LINZESS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 290MCG
Packaging :
Approval Date : 2012-08-30
Application Number : 202811
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LINZESS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 72MCG
Packaging :
Approval Date : 2017-01-25
Application Number : 202811
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Norway
Brand Name : Constella
Dosage Form : Kapsel, hard
Dosage Strength : 290 mikrog
Packaging : Boks 28item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Constella
Dosage Form : Kapsel, hard
Dosage Strength : 290 mikrog
Packaging : Boks 90item
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Constella
Dosage Form : Capsule
Dosage Strength : 290mcg
Packaging :
Approval Date : 26/11/2012
Application Number : 20111108000077
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Constella
Dosage Form : Capsule
Dosage Strength : 0.29mg
Packaging :
Approval Date : 20/06/2013
Application Number : 62684
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CONSTELLA
Dosage Form : CAPSULE
Dosage Strength : 145MCG
Packaging :
Approval Date :
Application Number : 2417162
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CONSTELLA
Dosage Form : CAPSULE
Dosage Strength : 290MCG
Packaging :
Approval Date :
Application Number : 2417170
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : CONSTELLA
Dosage Form : CAPSULE
Dosage Strength : 72MCG
Packaging :
Approval Date :
Application Number : 2469510
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Constella
Dosage Form : Hard Capsule
Dosage Strength : 290MCG
Packaging :
Approval Date : 2013-03-12
Application Number : 112801002
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info :
Registration Country : Norway
Brand Name : Constella
Dosage Form : Capsule, hard
Dosage Strength : 290 mcg
Packaging : Box
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Linaclotide
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 145MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
Regulatory Info :
Registration Country : India
Brand Name : Linaclotide
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 290MCG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LINACLOTIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 145MCG
Packaging :
Approval Date : 2023-02-07
Application Number : 209611
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LINACLOTIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 290MCG
Packaging :
Approval Date : 2023-02-07
Application Number : 209611
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LINACLOTIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 145MCG
Packaging :
Approval Date : 2021-02-09
Application Number : 209564
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LINACLOTIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 290MCG
Packaging :
Approval Date : 2021-02-09
Application Number : 209564
Regulatory Info : DISCN
Registration Country : USA